Health Canada has approved the Oxford-AstraZeneca COVID-19 vaccine and a related shot by the Serum Institute of India for use in this country with the first doses expected to arrive soon.
Cerebra Health is a Manitoba based life science company focused on improving access and quality of diagnostic technology for the assessment of sleep and sleep disorders. Cerebra works in partnership with leading sleep scientists and researchers within Canada with Cerebra’s focus being on market development and sales. Cerebra is currently responsible for bringing to market a state-of-the art technology, developed in Winnipeg by Dr. Magdy Younes, which revolutionizes how sleep is evaluated within both a lab and home setting. For more information on Cerebra Health please visit www.cerebrahealth.com